Achilles’ heel of high-risk multiple myeloma
Chromosomal abnormalities are found in most multiple myeloma (MM) patients. While myeloma patients have generally benefited from the advancement of treatment modalities over the years, the treatment outcome for patients having two or more high-risk prognostic events remains poor. In a novel step forward, a research team has embarked on a study which aims to address the unmet clinical need in this group of patients.
Materials provided by National University of Singapore. Note: Content may be edited for style and length.
Source link aaaaa